Cargando…

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya

BACKGROUND: Mucosal specimens are essential to evaluate compartmentalized immune responses to HIV vaccine candidates and other mucosally targeted investigational products. We studied the acceptability and feasibility of repeated mucosal sampling in East African clinical trial participants at low ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omosa-Manyonyi, Gloria, Park, Harriet, Mutua, Gaudensia, Farah, Bashir, Bergin, Philip J., Laufer, Dagna, Lehrman, Jennifer, Chinyenze, Kundai, Barin, Burc, Fast, Pat, Gilmour, Jill, Anzala, Omu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215886/ https://www.ncbi.nlm.nih.gov/pubmed/25360819 http://dx.doi.org/10.1371/journal.pone.0110228

Ejemplares similares

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya
por: Mutua, G, et al.
Publicado: (2012)

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
por: Nyombayire, Julien, et al.
Publicado: (2017)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya
por: Mugo, Peter Mwangi, et al.
Publicado: (2014)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020)

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2011)

Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults
por: Mutua, Gaudensia, et al.
Publicado: (2016)

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults—Experience from Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2018)

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers
por: Mutua, Gaudensia, et al.
Publicado: (2012)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
por: Mutua, Gaudensia, et al.
Publicado: (2019)

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda
por: Mayanja, Yunia, et al.
Publicado: (2023)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
por: Mpendo, Juliet, et al.
Publicado: (2015)

Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials
por: Langat, Robert K., et al.
Publicado: (2021)

Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya
por: Mwangi, Irene Ann, et al.
Publicado: (2023)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2015)

Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya
por: Podolak, Irene, et al.
Publicado: (2017)

Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2022)

Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery
por: Price, Matt A, et al.
Publicado: (2020)

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020)

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
por: Karita, Etienne, et al.
Publicado: (2009)

Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya
por: Chanzu, Nadia Musimbi, et al.
Publicado: (2015)

Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya
por: Maina, Anne Njeri, et al.
Publicado: (2016)

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
por: Jaoko, Walter, et al.
Publicado: (2010)

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)
por: Macharia, Lucy Wanjiku, et al.
Publicado: (2019)

Multidrug-Resistant Bacterial Isolates Recovered from Herbal Medicinal Products Sold in Nairobi, Kenya
por: Korir, Richard, et al.
Publicado: (2017)

Latent tuberculosis among household contacts of pulmonary tuberculosis cases in Nairobi, Kenya
por: Odera, Susan, et al.
Publicado: (2020)

Accelerating HIV vaccine development through meaningful engagement of local scientists and communities
por: Chinyenze, Kundai, et al.
Publicado: (2023)

Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission
por: Kamali, Anatoli, et al.
Publicado: (2015)

Quantifying rates of HIV-1 flow between risk groups and geographic locations in Kenya: A country-wide phylogenetic study
por: Nduva, George M, et al.
Publicado: (2022)

αEβ7, α4β7 and α4β1 integrin contributions to T cell distribution in blood, cervix and rectal tissues: Potential implications for HIV transmission
por: Perciani, Catia T., et al.
Publicado: (2018)

Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya
por: Njaanake, Kariuki H., et al.
Publicado: (2023)

Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2023)

Aflatoxin exposure in children age 6–12 years: a study protocol of a randomized comparative cross-sectional study in Kenya, East Africa
por: Wangia, Ruth Nabwire, et al.
Publicado: (2019)

HIV vaccines in 2022: where to from here?
por: Hannah, Stacey, et al.
Publicado: (2022)

Epidemiological and clinical characteristics of patients hospitalised with COVID-19 in Kenya: a multicentre cohort study
por: Ombajo, Loice Achieng, et al.
Publicado: (2022)

Electroporation (EP)-related technical errors experienced during an HIV vaccine clinical trial conducted in Rwanda and Uganda: lessons learned
por: Bayingana, R, et al.
Publicado: (2012)

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya
por: Wahome, Elizabeth, et al.
Publicado: (2016)

Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
por: Mohamed, Yehia S., et al.
Publicado: (2020)

Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling
por: Dawa, Jeanette, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8q6ler4aoliaj0ltodct5c6r4n